Report of Foreign Issuer (6-k)
September 11 2017 - 4:05PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT
TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of September 2017
Commission File Number 001-37381
MEDIGUS
LTD.
(Translation of registrant’s name into English)
Omer
Industrial Park, No. 7A, P.O. Box 3030, Omer 8496500, Israel
(Address of principal
executive offices)
Indicate by check mark whether the registrant
files or will file annual reports under cover Form 20-F or Form 40-F.
Form
20-F ☒ Form 40-F ☐
Indicate by check mark if the registrant is submitting the Form
6-K in paper as permitted by Regulation S-T Rule 101(b)(1): __
Indicate by check mark if the registrant is submitting the Form
6-K in paper as permitted by Regulation S-T Rule 101(b)(7): __
EXPLANATORY
NOTE
Medigus
Ltd., or the Company, hereby furnishes the following documents:
|
(i)
|
Notice and Proxy Statement
with respect to the Company’s extraordinary general meeting of the shareholders to be held on October 17, 2017, describing
the proposal to be voted upon at the meeting, the procedure for voting in person or by proxy at the meeting and various other
details related to the meeting; and
|
|
(ii)
|
a Proxy Card whereby holders of American depository
shares, evidenced by American depositary receipts, of the Company may vote at the meeting without attending in person.
|
The
Notice and Proxy Statement is furnished with this Form 6-K as Exhibit 99.1 and the Proxy Card is furnished with this Form 6-K
as Exhibit 99.2
.
This
Form 6-K is incorporated by reference into the Company’s Registration Statement on Form F-3 filed with the Securities and
Exchange Commission on August 24, 2016 (Registration No. 333- 213280) and its Registration Statement on Form S-8 filed with the
U.S. Securities and Exchange Commission on September 9, 2015 (Registration No. 333-206803).
SIGNATURE
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf
by the undersigned, thereunto duly authorized.
|
MEDIGUS LTD.
|
|
|
|
Date: September 11, 2017
|
By:
|
/s/ Oded Yatzkan
|
|
|
Oded Yatzkan
|
|
|
Chief Financial Officer
|
EXHIBIT
INDEX
4
Medigus (NASDAQ:MDGS)
Historical Stock Chart
From Mar 2024 to Apr 2024
Medigus (NASDAQ:MDGS)
Historical Stock Chart
From Apr 2023 to Apr 2024